Biotech

Avivagen will purchase another order of 150 kg of OxC-beta Livestock 10 percent premix from UNAHCO.

Avivagen (TSXV:VIV, OTCPINK:CHEXF) will purchase another order of 150 kg of OxC-beta Livestock 10 percent premix from UNAHCO.
As quoted in the press release:

The shipping date of the product is subject to receipt of an import permit. Based on recent conversations between executives at each of Avivagen and UNAHCO, Avivagen anticipates further orders from UNAHCO.

UNAHCO is the exclusive distributor for Avivagen’s OxC-beta™ Livestock in the Philippines, where it is now registered for use in all food animal species. UNAHCO is the wholly-owned feed and veterinary subsidiary of Unilab Inc., the biggest pharmaceutical company in the Philippines. UNAHCO provides a broad range of animal healthcare and nutrition products and programs to meet the requirements of both commercial and individual farmers in the Philippines as well as abroad. It is a leading producer of pig and poultry feed and has a distribution network that serves more than 3,000 outlets, supported by more than 100 field personnel.

Avivagen intends to accelerate market access and the commercial uptake of its OxC-beta™ Livestock product. Avivagen operates in Canada with headquarters in Ottawa and is actively working with large, vertically integrated livestock producers and feed companies in the United States, Europe, and Asia.

About Avivagen
Avivagen Inc. is a public company traded on the TSXV under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit www.avivagen.com.

About OxC-beta™ Technology and OxC-beta™ Livestock
OxC-beta™ Technology is derived from Avivagen discoveries about carotenoids, compounds that give certain fruits and vegetables their bright colors and is a non-antibiotic means of maintaining optimal health and growth. OxC-beta™ Livestock is a proprietary product shown to be effective and economic in replacing the antibiotics commonly added to livestock feeds.  OxC-beta™ Livestock is currently registered and available for sale in the Philippines, Taiwan and Thailand.

Avivagen’s product addresses one of the world’s leading risks to human health: the rise of antibiotic resistant bacteria, known as antimicrobial resistance. In order to preserve the effectiveness of antibiotics for human health, their use in the food chain as growth promoters for livestock animals must be eliminated. This use of antibiotics represents the single largest and majority use of antibiotics globally. Government agencies, global health organizations, livestock producers and end market food companies and their customers are now reaching consensus on the need to raise livestock without the use of antibiotics. Consequently the search is on for alternative products that will fill the gap to maintain health and productivity under modern production conditions.

Avivagen’s OxC-beta™ Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta™ Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than in-feed antibiotics.

Click here to read the full press release.

MARKETS

Markets
TSX19885.94+307.64
TSXV669.72+5.89
DOW33309.51+535.10
S&P 5004210.24+87.77
NASD12854.80+360.88
ASX6992.70-37.10

COMMODITIES

Commodities
Gold1794.26+2.69
Silver20.60+0.01
Copper3.69+0.04
Palladium2270.50+22.50
Platinum962.50+16.50
Oil93.10+1.17
Heating Oil3.49+0.08
Natural Gas8.42+0.22

DOWNLOAD FREE REPORTS

×